Phase 1 clinical study of the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid

BACKGROUND: The purpose of this research was to determine the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid (CHD-FA). METHODS: In this double-blind study, 30 male volunteers with predetermined atopy were randomly assigned to either Group A or Group B, ea...

Descripción completa

Detalles Bibliográficos
Autores principales: Gandy, Justin John, Meeding, Johanna Petronella, Snyman, Jacques René, van Rensburg, Constance Elizabeth Jansen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304339/
https://www.ncbi.nlm.nih.gov/pubmed/22427734
http://dx.doi.org/10.2147/CPAA.S25784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304339/
https://www.ncbi.nlm.nih.gov/pubmed/22427734
http://dx.doi.org/10.2147/CPAA.S25784

Ejemplares similares